Abstract:Key points Spinal muscular atrophy (SMA) is a health‐ and life‐limiting neuromuscular disorder caused by a deficiency in survival motor neuron (SMN) protein. While historically considered a motor neuron disease, current understanding of SMA emphasizes its systemic nature, which requires addressing affected peripheral tissues such as skeletal muscle in particular. Chronic physical activity is beneficial for SMA patients, however the cellular and molecular mechanisms of exercise biology are largely undefined in SMA. After a single bout of exercise, canonical responses such as skeletal muscle AMPK, p38, and PGC‐1α activation were preserved in SMA‐like Smn 2B/− animals. Furthermore, molecules involved in SMN transcription were also altered following physical activity. Collectively, these changes were coincident with an increase in full‐length SMN transcription and corrective SMN pre‐mRNA splicing. Our study advances understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression in muscle. Chronic physical activity is safe and effective in spinal muscular atrophy (SMA) patients, however the underlying cellular events that drive physiological adaptations are undefined. We examined the effects of a single bout of exercise on molecular mechanisms associated with adaptive remodelling in the skeletal muscle of Smn 2B/− SMA‐like mice. Skeletal muscles were collected from healthy Smn 2B/+ mice and Smn 2B/− littermates at pre‐ [postnatal day (P) 9], early‐ (P13) and late‐symptomatic (P21) stages to characterize SMA disease progression. Muscles were also collected from Smn 2B/− animals exercised to fatigue on a motorized treadmill. Intracellular signalling and gene expression were examined using Western blotting, confocal immunofluorescence microscopy, real‐time quantitative polymerase chain reaction (PCR), and endpoint PCR assays. Basal skeletal muscle AMP‐activated protein kinase (AMPK) and p38 mitogen‐activated protein kinase (p38) expression and activity were not affected by SMA‐like conditions. Canonical exercise responses such as AMPK, p38, and peroxisome proliferator‐activated receptor γ coactivator‐1α (PGC‐1α) activation were observed following a bout of exercise in Smn 2B/− animals. Furthermore, molecules involved in survival motor neuron (SMN) transcription including protein kinase B (AKT) and extracellular signal‐regulated kinases (ERK)/ ETS‐like gene 1 (ELK), were altered following physical activity. Acute exercise was also able to mitigate aberrant proteolytic signalling in the skeletal muscle of Smn 2B/− mice. Collectively, these changes were coincident with an exercise‐evoked increase in full‐length SMN mRNA expression. This study advances our understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression alongside AKT and ERK/ELK signalling. This article is protected by copyright. All rights reserved

Mechanisms of exercise‐induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy‐like mice

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

Peripheral Smn Restoration is Essential for Long-Term Rescue of A Severe Spinal Muscular Atrophy Mouse Model

Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes

Targeted-SMN insufficiency in Skeletal Muscle Stem Cells mediates non-cell autonomous loss of motor neurons at long term

Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models.

SMN depletion impairs skeletal muscle formation and maturation in a mouse model of SMA

SMN deficiency induces an early non-atrophic myopathy with alterations in the contractile and excitatory coupling machinery of skeletal myofibers in the SMN∆7 mouse model of spinal muscular atrophy

A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses

Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy

Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice

SMN protein is required throughout life to prevent spinal muscular atrophy disease progression

A large animal model of spinal muscular atrophy and correction of phenotype

SMN deficiency alters the CNS and the peripheral immune system in a mouse model of spinal muscular atrophy (SMA)

Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy

Regulation of Survival Motor Neuron Gene Expression by Calcium Signaling

Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment

Modulating the endoplasmic reticulum stress response attenuates neurodegeneration in a Caenorhabditiselegans model of spinal muscular atrophy

Impact of liver-specific survival motor neuron (SMN) depletion on central nervous system and peripheral tissue pathology

Myostatin Inhibition in Combination with Antisense Oligonucleotide Therapy Improves Outcomes in Spinal Muscular Atrophy.